Embera NeuroTherapeutics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $20K

  • Investors
  • 15

Embera NeuroTherapeutics General Information

Description

Operator of a pharmaceutical company intended to develop novel treatments to potentially treat a range of addictions. The company's medication reduces the cravings and loss of control that drive addiction by targeting multiple pathways, to maximize potential efficacy more than either drug used alone, enabling patients to abstain from smoking and drug use.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 365 Boston Post Road
  • Suite 212
  • Sudbury, MA 01776
  • United States
+1 (978)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, Manufacturing, Life Sciences
Corporate Office
  • 365 Boston Post Road
  • Suite 212
  • Sudbury, MA 01776
  • United States
+1 (978)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Embera NeuroTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series A2) 11-Sep-2020 $20K Completed Clinical Trials - Phase 2
11. Later Stage VC (Series B) 01-Aug-2020 Completed Clinical Trials - Phase 2
10. Later Stage VC (Series B) 09-Nov-2016 Completed Clinical Trials - Phase 1
9. Grant 01-Aug-2016 Completed Clinical Trials - Phase 1
8. Grant 26-Jul-2016 Completed Clinical Trials - Phase 1
7. Later Stage VC (Series A2) 29-Sep-2015 Completed Clinical Trials - Phase 1
6. Accelerator/Incubator 05-Aug-2015 Completed Clinical Trials - Phase 1
5. Grant 01-Jul-2014 Completed Clinical Trials - Phase 1
4. Later Stage VC (Series A2) 15-Aug-2011 $4.5M $9.5M Completed Startup
3. Early Stage VC (Series A) 03-Sep-2008 $3M $4.96M Completed Startup
To view Embera NeuroTherapeutics’s complete valuation and funding history, request access »

Embera NeuroTherapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A2
Series A1 1,357,100 $0.001000 $0.06 $1 $1 1x $1 3.74%
To view Embera NeuroTherapeutics’s complete cap table history, request access »

Embera NeuroTherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to develop novel treatments to potentially treat a range of addictions. Th
Drug Discovery
Sudbury, MA
2 As of 2024

South San Francisco, CA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Embera NeuroTherapeutics Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Achaogen Formerly VC-backed South San Francisco, CA
Spero Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 2 of 2 competitors. Get the full list »

Embera NeuroTherapeutics Patents

Embera NeuroTherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200360400-A1 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease Inactive 19-May-2017
EP-3592350-A4 Pharmaceutical compositions and uses thereof Pending 10-Mar-2017
CA-3055940-A1 Pharmaceutical compositions and uses thereof Pending 10-Mar-2017
AU-2018230521-B2 Pharmaceutical compositions and uses thereof Active 10-Mar-2017
US-11179377-B2 Pharmaceutical compositions and uses thereof Active 10-Mar-2017 A61K9/1611
To view Embera NeuroTherapeutics’s complete patent history, request access »

Embera NeuroTherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Embera NeuroTherapeutics Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Seven Funds Venture Capital Minority
Gulf South Angels Angel Group Minority
Technomark Life Sciences Venture Capital Minority
ROSE RESEARCH CENTER, LLC Corporation
BRF(Shreveport) Government Minority
You’re viewing 5 of 15 investors. Get the full list »

Embera NeuroTherapeutics FAQs

  • When was Embera NeuroTherapeutics founded?

    Embera NeuroTherapeutics was founded in 2005.

  • Where is Embera NeuroTherapeutics headquartered?

    Embera NeuroTherapeutics is headquartered in Sudbury, MA.

  • What is the size of Embera NeuroTherapeutics?

    Embera NeuroTherapeutics has 2 total employees.

  • What industry is Embera NeuroTherapeutics in?

    Embera NeuroTherapeutics’s primary industry is Drug Discovery.

  • Is Embera NeuroTherapeutics a private or public company?

    Embera NeuroTherapeutics is a Private company.

  • What is Embera NeuroTherapeutics’s current revenue?

    The current revenue for Embera NeuroTherapeutics is .

  • How much funding has Embera NeuroTherapeutics raised over time?

    Embera NeuroTherapeutics has raised $24.5M.

  • Who are Embera NeuroTherapeutics’s investors?

    Seven Funds, Gulf South Angels, Technomark Life Sciences, ROSE RESEARCH CENTER, LLC, and BRF(Shreveport) are 5 of 15 investors who have invested in Embera NeuroTherapeutics.

  • Who are Embera NeuroTherapeutics’s competitors?

    Achaogen and Spero Therapeutics are competitors of Embera NeuroTherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »